Form 4 Filing for ARS Pharmaceuticals, Inc. - Officer/Director Transaction

This filing details a Form 4 transaction for ARS Pharmaceuticals, Inc. (SPRY), filed on June 26, 2026. Reporting owner Kelly Michael, a director, acquired 30,000 shares through a stock option with a purchase price of $0.00. The option vests fully on June 24, 2027, or the date of the Issuer's 2027 annual meeting of stockholders. The underlying security is Common Stock, and post-transaction, 30,000 shares are owned. The option's exercise price is $10.54 and it expires on June 23, 2036. This transaction is classified as an acquisition of securities by a director.